Article
A Retrospective Chart Review of Children in Neurocutaneous Clinic Who May Benefit from Further Evaluation Beyond Neurofibromatosis Type I.
Cancer prevention research (Philadelphia, Pa.) - 1 Apr 2021
Hicks Stephanie R, Cozart Amanda K, Bellus Gary A, Schneider Kami W
Abstract excerpt
While most individuals with a clinical diagnosis of Neurofibromatosis type 1 (NF1) have a detectable pathogenic variant in the NF1 gene, other conditions have phenotypic features overlapping with NF1. Without molecular confirmation, individuals may be misdiagnosed and have a different underlying condition. Namely, if a child has constitutional mismatch repair deficiency (CMMRD), early detection and prevention...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
